Compare SNDA & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNDA | ORGO |
|---|---|---|
| Founded | 1990 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 501.8M | 539.1M |
| IPO Year | 1997 | N/A |
| Metric | SNDA | ORGO |
|---|---|---|
| Price | $32.55 | $5.06 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $28.00 | $8.00 |
| AVG Volume (30 Days) | 65.0K | ★ 3.1M |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $327,007,000.00 | ★ $465,218,000.00 |
| Revenue This Year | $25.63 | $2.51 |
| Revenue Next Year | $6.18 | $25.45 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 29.15 | 2.24 |
| 52 Week Low | $19.34 | $2.61 |
| 52 Week High | $33.50 | $7.08 |
| Indicator | SNDA | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 66.51 | 48.85 |
| Support Level | $32.19 | $5.09 |
| Resistance Level | $33.48 | $5.83 |
| Average True Range (ATR) | 0.80 | 0.45 |
| MACD | -0.08 | -0.10 |
| Stochastic Oscillator | 51.30 | 1.23 |
Sonida Senior Living Inc is an owner operator of senior housing communities in the United States in terms of resident capacity. It provides senior living services to the elderly, including independent living, assisted living, Respite Care and Temporary Care Programs, Home Care Services, and memory care services. The company's objective is to provide value to residents by providing quality senior housing services at reasonable prices. The basic service of the company is comprised of meals, housekeeping, laundry, 24-hour staffing, transportation, social and recreational activities, and healthcare monitoring.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.